Altered eotaxin-1 and interleukin-34 levels in obsessive-compulsive disorder: a case-control observational study in Bangladesh
10.24171/j.phrp.2024.0222
- Author:
Syed Ishtiaque HOSSAIN
1
;
Rapty SARKER
;
Sardar Mohammad ASHRAFUL ISLAM
;
Mohiuddin Ahmed BHUIYAN
;
MMA Shalahuddin QUSAR
;
Md. Rabiul ISLAM
Author Information
1. Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
- Publication Type:Original Article
- From:
Osong Public Health and Research Perspectives
2025;16(1):72-80
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objectives:Obsessive-compulsive disorder (OCD) is a prevalent mental health condition that impacts daily life. It is thought to be associated with genetic, biological, and structural brain changes, serotonergic abnormalities, altered neuromodulation, and environmental factors.Limited observational studies have examined cytokines in Bangladeshi patients with OCD. This study aimed to assess the levels of eotaxin-1 and interleukin (IL)-34 in individuals with this disorder.
Methods:This case-control observational study included 58 patients with OCD and 30 healthy controls (HCs) matched for age, sex, and body mass index. The severity of OCD was assessed using the Yale-Brown obsessive-compulsive scale (Y-BOCS). Psychiatrists evaluated participants according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Serum levels of eotaxin-1 and IL-34 were measured using enzyme-linked immunosorbent assay kits.
Results:Patients with OCD exhibited significantly higher serum eotaxin-1 levels (121.13 ± 7.84pg/mL) than HCs (85.52 ± 9.42 pg/mL). Conversely, IL-34 levels were considerably lower in patients than in HCs (119.02 ± 14.53 pg/mL vs. 179.96 ± 27.88 pg/mL). The Cohen d values for eotaxin-1 and IL-34 were 0.55 and −0.48, respectively. Among patients with OCD, a significantpositive correlation was found between serum eotaxin-1 level and Y-BOCS score, along with a negative correlation between serum eotaxin-1 and IL-34 levels.
Conclusion:The findings suggest that altered eotaxin-1 and IL-34 levels may be associated withOCD. These chemokines and cytokines could serve as primary tools for assessing the risk of OCD, warranting further clinical investigation. This could potentially support more extensive research and the development of diagnostic and therapeutic strategies targeting these pathways.
